These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9258989)

  • 1. Safety of cotinine in humans: physiologic, subjective, and cognitive effects.
    Hatsukami DK; Grillo M; Pentel PR; Oncken C; Bliss R
    Pharmacol Biochem Behav; 1997 Aug; 57(4):643-50. PubMed ID: 9258989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of cotinine on cigarette self-administration.
    Hatsukami D; Lexau B; Nelson D; Pentel PR; Sofuoglu M; Goldman A
    Psychopharmacology (Berl); 1998 Jul; 138(2):184-9. PubMed ID: 9718288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic effects of cotinine in abstinent cigarette smokers.
    Keenan RM; Hatsukami DK; Pentel PR; Thompson TN; Grillo MA
    Clin Pharmacol Ther; 1994 May; 55(5):581-90. PubMed ID: 8181202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose nicotine patch therapy. Percentage of replacement and smoking cessation.
    Dale LC; Hurt RD; Offord KP; Lawson GM; Croghan IT; Schroeder DR
    JAMA; 1995 Nov; 274(17):1353-8. PubMed ID: 7563559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cotinine: effects with and without nicotine.
    Hatsukami D; Pentel PR; Jensen J; Nelson D; Allen SS; Goldman A; Rafael D
    Psychopharmacology (Berl); 1998 Jan; 135(2):141-50. PubMed ID: 9497019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine withdrawal and psychiatric symptoms in cigarette smokers with schizophrenia.
    Dalack GW; Becks L; Hill E; Pomerleau OF; Meador-Woodruff JH
    Neuropsychopharmacology; 1999 Aug; 21(2):195-202. PubMed ID: 10432467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smokers deprived of cigarettes for 72 h: effect of nicotine patches on craving and withdrawal.
    Teneggi V; Tiffany ST; Squassante L; Milleri S; Ziviani L; Bye A
    Psychopharmacology (Berl); 2002 Nov; 164(2):177-87. PubMed ID: 12404080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of effect of 5HT3 antagonist in mediating subjective and behavioral responses to cotinine.
    Hatsukami DK; Jensen J; Brauer LH; Mooney M; Schulte S; Sofuoglu M; Pentel PR
    Pharmacol Biochem Behav; 2003 Apr; 75(1):1-7. PubMed ID: 12759107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progesterone improves cognitive performance and attenuates smoking urges in abstinent smokers.
    Sofuoglu M; Mouratidis M; Mooney M
    Psychoneuroendocrinology; 2011 Jan; 36(1):123-32. PubMed ID: 20675057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine patches and the subjective effects of cigarette smoking: a pilot study.
    Cárdenas L; Busto UE; MacDonald A; Corrigall WA
    Can J Clin Pharmacol; 2002; 9(4):175-82. PubMed ID: 12584575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up. One-year outcome and percentage of nicotine replacement.
    Hurt RD; Dale LC; Fredrickson PA; Caldwell CC; Lee GA; Offord KP; Lauger GG; Marŭsić Z; Neese LW; Lundberg TG
    JAMA; 1994 Feb; 271(8):595-600. PubMed ID: 8301791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of transdermal nicotine delivery on measures of acute nicotine withdrawal.
    Pickworth WB; Fant RV; Butschky MF; Henningfield JE
    J Pharmacol Exp Ther; 1996 Nov; 279(2):450-6. PubMed ID: 8930145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine patch use in pregnant smokers: nicotine and cotinine levels and fetal effects.
    Ogburn PL; Hurt RD; Croghan IT; Schroeder DR; Ramin KD; Offord KP; Moyer TP
    Am J Obstet Gynecol; 1999 Sep; 181(3):736-43. PubMed ID: 10486492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking.
    Benowitz NL; Zevin S; Jacob P
    Br J Clin Pharmacol; 1997 Mar; 43(3):259-67. PubMed ID: 9088580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cotinine on information processing in nonsmokers.
    Herzig KE; Callaway E; Halliday R; Naylor H; Benowitz NL
    Psychopharmacology (Berl); 1998 Jan; 135(2):127-32. PubMed ID: 9497017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine nasal spray for smoking cessation: pattern of use, side effects, relief of withdrawal symptoms, and cotinine levels.
    Hurt RD; Dale LC; Croghan GA; Croghan IT; Gomez-Dahl LC; Offord KP
    Mayo Clin Proc; 1998 Feb; 73(2):118-25. PubMed ID: 9472993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a 2-day abstinence from smoking on dietary, cognitive, subjective, and physiologic parameters among younger and older female smokers.
    Kos J; Hasenfratz M; Bättig K
    Physiol Behav; 1997 May; 61(5):671-8. PubMed ID: 9145936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The electronic-cigarette: effects on desire to smoke, withdrawal symptoms and cognition.
    Dawkins L; Turner J; Hasna S; Soar K
    Addict Behav; 2012 Aug; 37(8):970-3. PubMed ID: 22503574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting smoking cessation. Who will quit with and without the nicotine patch.
    Kenford SL; Fiore MC; Jorenby DE; Smith SS; Wetter D; Baker TB
    JAMA; 1994 Feb; 271(8):589-94. PubMed ID: 8301790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
    Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
    J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.